Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hong Kong Pharmaceutical Industry Association Executive Director Sabrina Chan On Competition and R&D in Hong Kong: An Interview with PharmAsia News (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

Hong Kong, with a population of just under 7 million and long known for its status as one of the most open markets in the world, can be a challenging market for pharma companies because roughly half of the drugs sold in the Special Administrative Region of China go through its Hospital Authority. It can take up to three years to get an approved product on its list of available products. The Hong Kong Association of the Pharmaceutical Industry, which represents 42 companies including multinational companies that operate in Hong Kong, is fighting to cut through the red tape and get innovative drugs to patients faster while trying to stay on top of a stubborn counterfeit problem, Executive Director Sabrina Chan told PharmAsia News' Hong Kong bureau in an exclusive interview.

You may also be interested in...



Hong Kong Government Explores Alternatives To Capping Public Health Care Costs

Six funding alternatives include social health insurance, out-of-pocket payments, medical savings accounts, voluntary or mandatory health insurance and personal health care reserves.

Hong Kong Government Explores Alternatives To Capping Public Health Care Costs

Six funding alternatives include social health insurance, out-of-pocket payments, medical savings accounts, voluntary or mandatory health insurance and personal health care reserves.

Hong Kong Government Explores Alternatives To Capping Public Health Care Costs

HONG KONG - Faced with inflationary costs and an aging population, Hong Kong's government is mulling plans to change the way it pays for health care

Related Content

UsernamePublicRestriction

Register

SC067238

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel